JHVEPhoto T2 Biosystems ( NASDAQ: TTOO ) said on Wednesday that the biotechnology company has regained compliance with Nasdaq's requirement related to the market value of listed securities. The company said it received a written notice from Nasdaq on May 21. The company was informed of the non-compliance on November 22 as it had failed to maintain a market value of listed securities of at least $35M for a period of 30 consecutive business days.
T2 Biosystems was required to maintain a market value of at least $35M for at least 10 consecutive trading days on or before May 20. The requirement was met on May 16. TTOO shares were trading -0.
92% pre-market. Source: Press Release More on T2 Biosystems T2 Biosystems, Inc. (TTOO) Q1 2024 Earnings Call Transcript T2 Biosystems GAAP EPS of -$2.
66, revenue of $2.06M T2 Biosystems shareholders vote to convert $15M CRG debt into equity Seeking Alpha’s Quant Rating on T2 Biosystems Historical earnings data for T2 Biosystems.